Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation

v3.10.0.1
Stock Based Compensation
9 Months Ended
Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Based Compensation

Note 6 – Stock Based Compensation

Equity Incentive Plans

2013 Equity Incentive Plan

In December 2013, the Company’s Board and stockholders approved the 2013 Equity Incentive Plan, providing for the issuance of equity-based instruments covering up to an initial total of 1,042,167 shares of common stock.

Effective on March 10, 2014, the Company’s Board and stockholders approved the First Amendment to the 2013 Equity Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the 2013 Equity Incentive Plan to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for this purpose the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options).

Effective March 27, 2014, the aggregate total number of shares which may be issued under the 2013 Equity Incentive Plan was increased to 2,335,967.

Effective on May 19, 2016, the Company’s stockholders approved the amendment and restatement of the 2013 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,150,000 shares, bringing the total number of approved shares to 4,485,967 under the 2013 Equity Incentive Plan.

Effective on May 16, 2018, the Company’s stockholders approved the amendment and restatement of the 2013 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,600,000 shares, bringing the total number of approved shares to 6,085,967 under the 2013 Equity Incentive Plan.

As of September 30, 2018, 2,079,035 shares of common stock remain available to be issued through equity-based instruments under the 2013 Equity Incentive Plan.

2014 Non-Employee Equity Compensation Plan

On March 6, 2014, the Company’s Board and stockholders approved the 2014 Non-Employee Equity Compensation Plan for the issuance of equity-based instruments covering up to 250,000 shares of common stock to directors and other non-employees.

Effective on May 19, 2016, the Company’s stockholders approved the amendment and restatement of the 2014 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 350,000 shares, bringing the total number of approved shares to 600,000 under the 2014 Non-Employee Equity Compensation Plan.

Effective on May 16, 2018, the Company’s stockholders approved the amendment and restatement of the 2014 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 250,000 shares, bringing the total number of approved shares to 850,000 under the 2014 Non-Employee Equity Compensation Plan.

As of September 30, 2018, 366,829 shares of common stock remain available to be issued through equity-based instruments under the 2014 Non-Employee Equity Compensation Plan.

2015 Performance Share Unit Plan

On April 10, 2015, the Company’s Board approved the Energous Corporation 2015 Performance Share Unit Plan (“Performance Share Plan”), under which 1,310,104 shares of common stock became available for issuance as PSUs to a select group of employees and directors, subject to approval by the stockholders. On May 21, 2015, the Company’s stockholders approved the Performance Share Plan.

Note 6 – Stock Based Compensation, continued

Effective on May 16, 2018, the Company’s stockholders approved the amendment and restatement of the 2014 Non-employee Compensation Plan to increase the number of shares reserved for issuance thereunder by 1,400,000 shares, bringing the total number of approved shares to 2,710,104 under the 2015 Performance Share Unit Plan.

 

As of September 30, 2018, 1,431,951 shares of common stock remain available to be issued through equity-based instruments under the Performance Share Unit Plan.

 

 

 

Note 6 – Stock Based Compensation, continued

 

2017 Equity Inducement Plan

 

On December 28, 2017, the Board approved the 2017 Equity Inducement Plan. Under the plan, the Board reserved 600,000 shares of common stock for the grant of RSUs. These grants will be administered by a committee of the Board or the Board acting as a committee. These awards will be granted to individuals who (a) are being hired as an employee by the Company or any subsidiary and such award is a material inducement to such person being hired; (b) are being rehired as an employee following a bona fide period of interruption of employment with the Company or any subsidiary; or (c) will become an employee of the Company or any subsidiary in connection with a merger or acquisition.

 

As of September 30, 2018, 311,000 shares of common stock remain available to be issued through equity-based instruments under the 2017 Equity Inducement Plan.

Employee Stock Purchase Plan

On April 10, 2015, the Company’s Board approved the ESPP, under which shares of common stock were reserved for purchase by the Company’s employees, subject to approval by the stockholders. On May 21, 2015, the Company’s stockholders approved the ESPP. Employees may designate an amount not less than 1% but not more than 10% of their annual compensation, but for not more than 7,500 shares during an offering period. An offering period shall be six months in duration commencing on or about January 1 and July 1 of each year. The exercise price of the option will be the lesser of 85% of the fair market of the common stock on the first business day of the offering period and 85% of the fair market value of the common stock on the applicable exercise date.

As of September 30, 2018, 376,463 shares of common stock remain available to be issued under the ESPP. As of September 30, 2018, employees have contributed $179,583 through payroll withholdings to the ESPP for the current eligibility period. Shares will be deemed delivered on December 31, 2018 for the current eligibility period.

Stock Option Activity

The following is a summary of the Company’s stock option activity during the nine months ended September 30, 2018:

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Life In

Years

 

 

Intrinsic

Value

 

Outstanding at January 1, 2018

 

 

1,037,239

 

 

$

4.80

 

 

 

6.4

 

 

$

15,198,044

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(380,745

)

 

 

3.47

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2018

 

 

656,494

 

 

$

5.57

 

 

 

4.9

 

 

$

2,986,926

 

Exercisable at January 1, 2018

 

 

1,037,239

 

 

$

4.80

 

 

 

6.4

 

 

$

15,198,044

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(380,745

)

 

 

3.47

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2018

 

 

656,494

 

 

$

5.57

 

 

 

4.9

 

 

$

2,986,926

 

 

As of September 30, 2018, the unamortized value of options was $0.     

Restricted Stock Units (“RSUs”)                                                          

During the nine months ended September 30, 2018, the Compensation Committee of the Board (“Compensation Committee”) granted various directors and consultants RSUs under which the holders have the right to receive an aggregate 175,826 shares of common stock. These awards were granted under the 2014 Non-Employee Equity Compensation Plan. The awards granted vest over terms from one to four years.

 

Note 6 – Stock Based Compensation, continued

During the nine months ended September 30, 2018, the Compensation Committee granted various employees RSU awards under the 2013 Equity Incentive Plan under which the holders have the right to receive an aggregate 459,550 shares of common stock. The majority of these awards granted vest over terms ranging from one to four years.

During the nine months ended September 30, 2018, the Compensation Committee granted employees RSU awards under the 2017 Equity Inducement Plan under which the holders have the right to receive 289,000 shares of common stock. The awards vest over four years beginning on the anniversary of the grant date.

The Company accounts for RSUs granted to consultants using the accounting guidance included in ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with ASC 505-50, the Company estimates the fair value of the unvested portion of the RSU award each reporting period using the closing price of common stock.

As of September 30, 2018, the unamortized value of the RSUs was $27,341,086. The unamortized amount will be expensed over a weighted average period of 2.5 years. A summary of the activity related to RSUs for the nine months ended September 30, 2018 is presented below:

 

 

 

Total

 

 

Weighted

Average

Grant

Date Fair

Value

 

Outstanding at January 1, 2018

 

 

2,274,325

 

 

$

13.75

 

RSUs granted

 

 

924,376

 

 

$

19.54

 

RSUs forfeited

 

 

(178,058

)

 

$

14.10

 

RSUs vested

 

 

(743,647

)

 

$

13.80

 

Outstanding at September 30, 2018

 

 

2,276,996

 

 

$

16.02

 

 

Performance Share Units (“PSUs”)

Performance share units (“PSUs”) are grants that vest upon the achievement of certain performance goals. The goals are related to the Company’s market capitalization or market share price of the common stock.

The PSUs originally issued during 2015 to certain board members and senior management are earned based on the Company’s achievement of market capitalization growth between the effective date of the employment agreement and the end of the initial employment period. If the Company’s market capitalization is $100 million or less, no PSUs will be earned. If the Company reaches a market capitalization of $1.1 billion or more, 100% of the PSUs will be earned. For market capitalization between $100 million and $1.1 billion, the percentage of PSUs earned will be determined on a quarterly basis based on straight line interpolation.

The Company determined that the PSUs were equity awards with both market and service conditions. The Company utilized a Monte Carlo simulation to determine the fair value of the market condition, as described below. Grantees of PSUs are required to be employed through December 31, 2018 in order to earn the entire award, if and when vested. No PSUs were granted during the nine months ended September 30, 2018.

 

The fair value of the grants of PSUs to purchase a total of 1,342,061 shares of common stock (including 1,278,153 PSUs granted under the 2015 Performance Share Unit Plan and 63,908 granted as an inducement) was determined to be approximately $3,218,000, and is amortized over the service period of May 21, 2015 through December 31, 2018, on a straight-line basis.

On October 24, 2016, the Compensation Committee granted Mr. Rizzone a PSU award under the 2013 Equity Incentive Plan under which Mr. Rizzone has the right to receive 150,000 shares of common stock. The shares of this award vest upon the Company’s stock price meeting specific targets.

For this PSU award, a Monte Carlo simulation was used to determine the fair value at each of the five target prices of the Company’s common stock, using a market capitalization of $298,857,000, dividend yield of 0%, expected volatility of 75% and a risk-free interest rate of 0.66%.

The fair value of the PSUs granted to Mr. Rizzone under the 2013 Equity Incentive Plan was determined to be $2,332,000, and was amortized over the estimated service period from October 24, 2016 through October 30, 2017.

Note 6 – Stock Based Compensation, continued

Amortization for all PSU awards was $207,206 and $399,867 for the three months ended September 30, 2018 and 2017, respectively, and $614,862 and $1,601,160 for the nine months ended September 30, 2018 and 2017, respectively.

At September 30, 2018, the unamortized value of all PSUs was approximately $204,954. The unamortized amount will be expensed over a weighted average period of 0.3 years. A summary of the activity related to PSUs for the nine months ended September 30, 2018 is presented below:

 

 

 

Total

 

 

Weighted

Average Grant

Date Fair Value

 

Outstanding at January 1, 2018

 

 

951,657

 

 

$

2.65

 

PSUs granted

 

 

 

 

 

-

 

PSUs forfeited

 

 

 

 

 

-

 

PSUs vested

 

 

(80,098

)

 

 

2.65

 

Outstanding at September 30, 2018

 

 

871,559

 

 

 

2.65

 

 

 

Deferred Stock Units (“DSUs”)

On January 4, 2016, the Compensation Committee granted to John Gaulding, Director and Chairman of the Board, DSUs under the 2014 Non-Employee Equity Compensation Plan for which Mr. Gaulding has the right to receive 14,953 shares of the Company’s common stock. These shares were issued to Mr. Gaulding in lieu of $125,000 of his anticipated compensation for his services on the Board, including $75,000 worth of DSUs and $50,000 of his regular board stipends. The award granted vests fully on the first anniversary of the grant date. There was no amortization for both the three months ended September 30, 2018 and 2017. Amortization was $0 and $1,362 for the nine months ended September 30, 2018 and 2017, respectively.

As of September 30, 2018, the DSUs were fully amortized and are no longer outstanding.

    

Employee Stock Purchase Plan (“ESPP”)

The recently completed offering period for the ESPP was January 1, 2018 through June 30, 2018. During the year ended December 31, 2017, there were two offering periods for the ESPP. The first offering period started on January 1, 2017 and concluded on June 30, 2017. The second offering period started on July 1, 2017 and concluded on December 31, 2017.  

The weighted-average grant-date fair value of the purchase option for each designated share purchased under this plan was approximately $9.72 and $5.88 for the nine months ended September 30, 2018 and 2017, respectively, which represents the fair value of the option, consisting of three main components: (i) the value of the discount on the enrollment date, (ii) the proportionate value of the call option for 85% of the stock and (iii) the proportionate value of the put option for 15% of the stock. The Company recognized compensation expense for the plan of $67,174 and $474,920 for the three and nine months ended September 30, 2018, respectively and $79,046 and $266,398 for the three and nine months ended September 30, 2017, respectively.

Note 6 – Stock Based Compensation, continued

The Company estimated the fair value of options granted during the nine months ended September 30, 2018 and 2017 using the Black-Scholes option pricing model. The fair values of stock options granted were estimated using the following assumptions:

 

 

 

Nine Months Ended

September 30, 2018

 

 

Nine Months Ended

September 30, 2017

 

Stock price

 

$14.48 - $22.34

 

 

$16.08 - $17.59

 

Dividend yield

 

 

0

%

 

 

0

%

Expected volatility

 

72% - 177%

 

 

56% - 66%

 

Risk-free interest rate

 

1.61% - 2.14%

 

 

0.62% - 1.11%

 

Expected life

 

6 months

 

 

6 months

 

 

Note 6 – Stock Based Compensation, continued

 

Stock-Based Compensation Expense

The following tables summarize total stock-based compensation costs recognized for the three and nine months ended September 30, 2018 and 2017:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Stock options

 

$

-

 

 

$

246,617

 

 

$

-

 

 

$

738,599

 

RSUs

 

 

3,578,276

 

 

 

3,843,186

 

 

 

11,714,962

 

 

 

9,865,351

 

PSUs

 

 

207,206

 

 

 

399,867

 

 

 

614,862

 

 

 

1,601,160

 

ESPP

 

 

67,174

 

 

 

79,046

 

 

 

474,920

 

 

 

266,398

 

DSU

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,362

 

Total

 

$

3,852,656

 

 

$

4,568,716

 

 

$

12,804,744

 

 

$

12,472,870

 

 

The total amount of stock-based compensation was reflected within the statements of operations as:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Research and development

 

$

2,051,986

 

 

$

2,558,472

 

 

$

7,594,209

 

 

$

6,643,094

 

Sales and marketing

 

 

352,941

 

 

 

281,518

 

 

 

1,022,832

 

 

 

782,366

 

General and administrative

 

 

1,447,729

 

 

 

1,728,726

 

 

 

4,187,703

 

 

 

5,047,410

 

Total

 

$

3,852,656

 

 

$

4,568,716

 

 

$

12,804,744

 

 

$

12,472,870